Subscribe To
Analysts think sales of abbvie's migraine drugs will each top $2 billion
Two new migraine treatments from AbbVie Inc. ( ABBV , Financial) could help offset any headaches caused...
January 31, 2022, 4:48 pm
Analysts think sales of abbvie's migraine drugs will each top $2 billion
Two new migraine treatments from AbbVie Inc. ( ABBV , Financial) could help offset any headaches caused...
January 31, 2022, 4:48 pm
Analysts think sales of abbvie's migraine drugs will each top $2 billion
Two new migraine treatments from AbbVie Inc. ( ABBV , Financial) could help offset any headaches caused...
January 31, 2022, 4:48 pm
Braxia scientific says it continues psychedelic-based clinical research trials to support future drug development
Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) said that its scientists continue to carry out multiple psychedelic-based clinical research trials, addi...
January 31, 2022, 8:58 am
Braxia scientific says it continues psychedelic-based clinical research trials to support future drug development
Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) said that its scientists continue to carry out multiple psychedelic-based clinical research trials, addi...
January 31, 2022, 8:58 am
Braxia scientific says it continues psychedelic-based clinical research trials to support future drug development
Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) said that its scientists continue to carry out multiple psychedelic-based clinical research trials, addi...
January 31, 2022, 8:58 am
Arcellx sets ipo terms, looks to raise up to $140.3 million
Arcellx Inc. ACLX, has set terms for its initial public offering, in which the Maryland-based biotechnology company, which is developing cancer ...
January 31, 2022, 8:30 am
Arcellx sets ipo terms, looks to raise up to $140.3 million
Arcellx Inc. ACLX, has set terms for its initial public offering, in which the Maryland-based biotechnology company, which is developing cancer ...
January 31, 2022, 8:30 am
Arcellx sets ipo terms, looks to raise up to $140.3 million
Arcellx Inc. ACLX, has set terms for its initial public offering, in which the Maryland-based biotechnology company, which is developing cancer ...
January 31, 2022, 8:30 am
Down 57% in a month, is there more pain for tg therapeutics stock?
The stock price of TG Therapeutics (NASDAQ: TGTX), a commercial stage biopharmaceutical company focused on the development of novel ...
January 31, 2022, 5:00 am
Down 57% in a month, is there more pain for tg therapeutics stock?
The stock price of TG Therapeutics (NASDAQ: TGTX), a commercial stage biopharmaceutical company focused on the development of novel ...
January 31, 2022, 5:00 am
Down 57% in a month, is there more pain for tg therapeutics stock?
The stock price of TG Therapeutics (NASDAQ: TGTX), a commercial stage biopharmaceutical company focused on the development of novel ...
January 31, 2022, 5:00 am
Imugene secures japanese grant notice for oncolytic virotherapy cf33 patent
Imugene Ltd (ASX:IMU, OTC:IUGNF) has received a notice of grant from the Japanese Patent Office for Patent Application number 2019-507161 which protec...
January 30, 2022, 7:52 pm
Imugene secures japanese grant notice for oncolytic virotherapy cf33 patent
Imugene Ltd (ASX:IMU, OTC:IUGNF) has received a notice of grant from the Japanese Patent Office for Patent Application number 2019-507161 which protec...
January 30, 2022, 7:52 pm
Imugene secures japanese grant notice for oncolytic virotherapy cf33 patent
Imugene Ltd (ASX:IMU, OTC:IUGNF) has received a notice of grant from the Japanese Patent Office for Patent Application number 2019-507161 which protec...
January 30, 2022, 7:52 pm
Enveric biosciences to participate in upcoming investor conferences in february 2022
NAPLES, Fla. , Jan. 27, 2022 /PRNewswire/ - Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company...
January 27, 2022, 7:30 am
Enveric biosciences to participate in upcoming investor conferences in february 2022
NAPLES, Fla. , Jan. 27, 2022 /PRNewswire/ - Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company...
January 27, 2022, 7:30 am
Enveric biosciences to participate in upcoming investor conferences in february 2022
NAPLES, Fla. , Jan. 27, 2022 /PRNewswire/ - Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company...
January 27, 2022, 7:30 am
Alector, inc: a newer biotech company with big potential
Biotech companies have seen an economic boom lately thanks to the COVID-19 Pandemic and the need for effective ...
January 26, 2022, 5:47 am
Alector, inc: a newer biotech company with big potential
Biotech companies have seen an economic boom lately thanks to the COVID-19 Pandemic and the need for effective ...
January 26, 2022, 5:47 am